M.S. Kuruvilla

P1.11.36 Strengthening Real World Evidence Generation Through an Expanding Multicenter Canadian Lung Cancer Registry

P. Wheatley-Price, Leah C. Young, Philippe Joubert, F. Gwadry Sridhar et autres

ca, us, gb (code pays fourni par la source)

2788P Real-world third-line treatment patterns and outcomes for recurrent or extensive stage small cell lung cancer (SCLC) in the Canadian small cell lung cancer database (CASCADE)

M-F. Damours, L.J. Zhan, M. John Gill, K. Khan et autres

ca (code pays fourni par la source)

2763P Treatment patterns and outcomes of clinical stage I small cell lung cancer (SCLC) in the Canadian SCLC database (CASCADE)

Sandra Mercier, L.J. Zhan, S. Raptis, F. Al-Agha et autres

ca (code pays fourni par la source)

LBA37 Final results: Randomized assessment of cisplatin dosing interval for ototoxicity (RADIO) trial comparing chemoradiation (CRT) with cisplatin q3weekly to weekly for locally advanced squamous cell carcinoma of the head and neck (LASCCHN)

M.S. Kuruvilla, Brandon M. Meyers, Martin Smoragiewicz, Paul Stewart et autres

ca (code pays fourni par la source)

1793P Treatment and outcomes of limited disease small cell lung cancer (LD-SCLC) in the Canadian small cell lung cancer database (CASCADE)

Sara Moore, L.J. Zhan, D. Chowdhury, R. Rittberg et autres

ca, ie (code pays fourni par la source)

940P Programmed death-ligand 1 (PDL1) expression and real-world outcomes in resected, early-stage non-small cell lung cancer (NSCLC)

P.K. Cheema, I. Syed, F. Gwadry-Sridhar, M. Rakibuz-Zaman et autres

ca (code pays fourni par la source)

A Review of Warfarin Dosing and Monitoring

M.S. Kuruvilla, Cheryle Gurk‐Turner

"A Review of Warfarin Dosing and Monitoring." Baylor University Medical Center Proceedings, 14(3), pp. 305–306

us (code pays fourni par la source)